Solvar Ltd (SVR)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 1.385 |
|---|---|
| 52-week range | 1.365 – 1.980 |
| Return, 1 month / 3 months | −6.4% / −5.3% |
| Return, 1 year / 3 years | −2.0% / +66.0% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 32.6% |
| Worst drawdown (1 year) | -25.2% |
| Average daily value traded | 0.30M AUD |
| Dividend yield | 14.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Solvar is an Australian consumer finance company that provides loans to individuals, with a focus on vehicle financing for used cars and light commercial vehicles. It also offers small personal and short-term loans through its lending brands. Its customers are mainly people in Australia and New Zealand who need finance that mainstream banks may not readily provide. The company is based in Australia and operates through a branch and broker network as well as online channels.
The shares are listed on the Australian Securities Exchange in Australia under the code SVR, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Solvar Ltd (SVR) trades on the Australian Securities Exchange in Australia. It last closed at AUD 1.385 on 22 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 341 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.0% and over the last three months it fell 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -8.6% | ||
| From 52-week high | -29.3% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.3% | ||
| 6-month return | -5.9% | ||
| 12-month return, skipping the last month | 4.8% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.2% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 0.30M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 75 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 14.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | −6.4% |
| 3 months | −5.3% |
| 6 months | −5.9% |
| 1 year | −2.0% |
| 3 years | +66.0% |
| 5 years | −32.9% |
Signals
| 50-day / 200-day average | 1.507 / 1.515 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.038 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Sep 2026 | AUD 0.0850 |
| 4 Mar 2026 | AUD 0.0850 |
| 11 Dec 2025 | AUD 0.0250 |
| 3 Sep 2025 | AUD 0.0800 |
| 4 Mar 2025 | AUD 0.0600 |
| 3 Sep 2024 | AUD 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.